Accuracy of HER2 testing in breast cancer is of enormous importance as a subsequent therapy decision for or against chemotherapy and Herceptin therapy is directly subjected to the HER2 status determined by the pathologists [3]. Here, ERBB2 is linked to breast carcinoma.